Revised Mailing Standards for Firearms

The USPS proposes to amend Publication 52 to expand the scope of mailable firearms to include handguns, aligning with the Department of Justice's Office of Legal Counsel opinion that Section 1715 of 18 U.S.C. is unconstitutional as applied to constitutionally protected firearms. The proposed revisions would allow lawful handguns to be mailed under the same terms and conditions as rifles and shotguns. Comments are due May 4, 2026.

Medline Angiographic Kit Recall - Syringe Adaptor Unwinding Risk

Health Canada issued a Type I recall for Medline Namic Custom Angiographic Kits (catalog numbers 60700513, 60701152, 60700465) due to potential risk of the syringe rotating adaptor unwinding during use, which may cause procedural delays or death. Healthcare facilities must immediately stop using affected Namic RA Syringes and discard them. Recall identification number RA-81841.

Aved Products Recall - Unauthorized Ophthalmic Solutions

Health Canada issued a Type III recall for Aved ophthalmic solutions from Labtician Ophthalmics, Inc. Nine products were sold without market authorization (DIN) in Canada due to third-party branding issues. Affected products include various atropine sulfate solutions (0.01%-0.05%), fluorescein/proparacaine, insulin ophthalmic, mitomycin, moxifloxacin, and combination steroid/antibiotic solutions. Distribution is national in Canada with recall classification RA-81839.

Olympus Connecting Tubes Premature Failure Recall

Health Canada issued a Type II medical device recall for Olympus Medical Systems Corp. connecting tubes (models MAJ-2110 through MAJ-2330) due to premature failure where lock levers detach or break earlier than expected in Version 2 products. Olympus will remove prior versions from the market and replace them with the current design. Affected parties should identify, quarantine, and contact the manufacturer for replacement.

AneurysmFlow Medical Device Recall - Unreliable mafa Ratio

Health Canada issued a Type II recall for AneurysmFlow software (Model 1.4) manufactured by Philips Medical Systems Nederland B.V. The recall addresses unreliable mafa ratio measurements that provide inaccurate prognostic information for aneurysm occlusion following flow diverter stent treatment. Despite existing cautions in the instructions for use, the displayed mafa ratio may still influence intraprocedural clinical decisions, potentially resulting in incorrect patient treatment choices.

Weekly Balance Sheet Report

The Bank of England published its weekly statistical report for 1 April 2026, showing reserves balances of £645,085mn and notes in circulation of £97,061mn. The report provides updated balance sheet data comparing the current week to the previous week (25 March 2026), with reserves decreasing by £2,523mn and notes in circulation increasing by £415mn.

Annual Plan: Competition Priorities for Affordability and Choice

The Competition Bureau Canada released its 2026-2027 Annual Plan outlining enforcement priorities focused on anti-competitive conduct, mergers affecting essential household costs (food and housing), and deceptive marketing practices. The plan signals increased scrutiny of hidden costs and barriers to competition, particularly in sectors impacting Canadian household affordability.

Fund Finance Navigator - NAV Lending and Securitization Guide

Cadwalader, Wickersham & Taft LLP released an updated Fund Finance Navigator covering NAV lending, securitization, subscription facilities, and side letters. The guide reorganizes existing Fund Finance Friday articles into a new jurisdiction-specific and structured finance format. This is a compilation and organizational update of previously published legal analysis for fund finance practitioners.

40 Years of Private Equity: From Buyouts to Creative Capital Solutions

Akin Gump lawyers published an analysis of private equity's 40-year evolution, from leveraged buyouts in the 1980s to diversified multi-asset strategies. The article projects industry AUM to reach $12 trillion and discusses how sponsors now pursue creative capital solutions and sector-specific value creation amid $2.5 trillion in uncalled capital globally.

Private Equity Transportation M&A, $11B Georgia Highway, Rail Deals

Akin Gump attorneys published their annual private equity transportation outlook, noting decreased freight investments in 2025 due to trade uncertainties and rate concerns. The article highlights the $11 billion Georgia SR 400 highway project—the largest U.S. greenfield P3—as a key transaction and discusses rail consolidation trends including Union Pacific-Norfolk Southern merger activity.